Sarasin Partners Llp buys $218,722,348 stake in Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL) : Sarasin Partners Llp scooped up 286,850 additional shares in Colgate-Palmolive Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 14, 2016. The investment management firm now holds a total of 3,024,787 shares of Colgate-Palmolive Company which is valued at $218,722,348.Colgate-Palmolive Company makes up approximately 3.49% of Sarasin Partners Llp’s portfolio.

Other Hedge Funds, Including , Toth Financial Advisory Corp reduced its stake in CL by selling 2,832 shares or 3.61% in the most recent quarter. The Hedge Fund company now holds 75,665 shares of CL which is valued at $5,459,986. Colgate-Palmolive Company makes up approx 1.64% of Toth Financial Advisory Corp’s portfolio.Murphy Pohlad Asset Management reduced its stake in CL by selling 350 shares or 1.09% in the most recent quarter. The Hedge Fund company now holds 31,625 shares of CL which is valued at $2,282,060. Colgate-Palmolive Company makes up approx 1.73% of Murphy Pohlad Asset Management’s portfolio.Chicago Trust Co Na reduced its stake in CL by selling 378 shares or 6.49% in the most recent quarter. The Hedge Fund company now holds 5,450 shares of CL which is valued at $393,490. Colgate-Palmolive Company makes up approx 0.18% of Chicago Trust Co Na’s portfolio.Eqis Capital Management boosted its stake in CL in the latest quarter, The investment management firm added 1,854 additional shares and now holds a total of 15,885 shares of Colgate-Palmolive Company which is valued at $1,159,128. Colgate-Palmolive Company makes up approx 0.07% of Eqis Capital Management’s portfolio.

Colgate-Palmolive Company opened for trading at $72.4 and hit $72.9 on the upside on Friday, eventually ending the session at $72.31, with a gain of 0.21% or 0.15 points. The heightened volatility saw the trading volume jump to 28,74,972 shares. Company has a market cap of $64,464 M.

On the company’s financial health, Colgate-Palmolive Company reported $0.70 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.69. The company had revenue of $3845.00 million for the quarter, compared to analysts expectations of $3859.81 million. The company’s revenue was down -5.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.70 EPS.

Investors should note that on Sep 8, 2016, Colgate-Palmolive Company announced a cash dividend of $0.3900. The company’s management has announced Oct 20, 2016 as the ex-dividend date and fixed the record date on Oct 24, 2016. The payable date has been fixed on Nov 15, 2016.

Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Upgraded by BofA/Merrill to ” Buy” on Sep 12, 2016. Colgate-Palmolive Company was Downgraded by Exane BNP Paribas to ” Neutral” on Jul 29, 2016.

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.

Leave a Reply

Colgate-Palmolive Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Colgate-Palmolive Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.